Mirror Trial - Follow-Up Management of Peripheral Arterial Intervention With Clopidogrel
NCT00163267
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Peripheral Vascular Diseases
Interventions
DRUG:
clopidogrel
Sponsor
University Hospital Tuebingen